Heme arginate

N/A

Report date: 2022/02/18 10:00:25
NME

Base Information

Drug NameHeme arginate
Drug Alias NameHemin - Orphan EuropeNormosang
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHemoglobin HbA modulators
TargetsHemoglobin HbA
Therapy Area/IndicationsPrimary Graft DysfunctionReperfusion InjuryPorphyria, Acute Intermittent
Global Approved IndicationsPorphyria, Acute Intermittent
Approved Indications in ChinaN/A
Original Approved Country/TerritoryFrance
Original Approved Date1995/01/01
Country/TerritoryUnited KingdomFranceJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesCmic Group
Inactive CompaniesThe University Of Edinburgh
Active IndicationsPorphyria, Acute Intermittent
Inactive IndicationsPrimary Graft DysfunctionReperfusion Injury

Other Information

ATC CodeB06AB
Related LinksWikipedia